The Endogenous Cannabinoid and the Nitricoxidergic Systems in the Modulation of Stress Responses

Int J Mol Sci. 2023 Feb 2;24(3):2886. doi: 10.3390/ijms24032886.

Abstract

The effects on stress-induced analgesia (SIA) from endogenous cannabinoid system (ECS) and nitric oxide (NO) interaction after 1 h of restraint stress were evaluated in male Wistar rats. The animals were subjected to 1 h of restraint and then injected with different combinations of cannabinoid receptor type 1 agonist anandamide (AEA) or antagonist AM251 along with an NO donor, NO precursor, or inhibitor of NO synthase. Nociception was evaluated using paw pressure (PP) or hot plate (HP) tests. AEA was administered immediately after the end of restraint-SIA (r-SIA). Administration of NO precursor reversed the pronociceptive effect of the CB1 agonist on r-SIA. Both the CB1 antagonist and the NOS inhibitor neutralized the pro-analgesic effect of L-arginine (L-arg). Administration of an NO donor, instead, increased r-SIA. Our experiments confirmed that the endogenous cannabinoid and the NO-ergic systems interact in the modulation of r-SIA. This interaction probably implies NO as a second messenger of the ECS.

Keywords: anandamide (AEA); antinociception; hot plate test; nitric oxide (NO); paw pressure test; restraint stress (RS).

MeSH terms

  • Animals
  • Cannabinoid Receptor Agonists / pharmacology
  • Cannabinoids* / pharmacology
  • Endocannabinoids* / pharmacology
  • Male
  • Nitric Oxide / metabolism
  • Nociception
  • Pain
  • Polyunsaturated Alkamides / pharmacology
  • Rats
  • Rats, Wistar
  • Receptor, Cannabinoid, CB1
  • Stress, Physiological

Substances

  • Cannabinoid Receptor Agonists
  • Cannabinoids
  • Endocannabinoids
  • Polyunsaturated Alkamides
  • Receptor, Cannabinoid, CB1
  • Nitric Oxide

Grants and funding

This study was supported by Grant No. 92/24.06.2020 from the Medical Science Council of the Medical University—Sofia.